Svetlana Paskaš (Svetlana Paskas)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

Institute for Biological Research Siniša Stanković

Uim University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Biological Research Siniša Stanković Sep 1o 2016

Serbia

Post Doc :: Immunology

Education History

Uim University Jun 1o 2002 - Feb 20o 2006

Germany

PHD :: Pharmacology

Publications

Svetlana Paskaš, Philipp Stockmann, Sanja Mijatović, Lydia Kuhnert, Walther Honscha, Evamarie Hey-Hawkins, Danijela Maksimović-Ivanić
Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Svetlana Paskaš, Blagoje Murganic, Robert Kuhnert, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo. Molecules (Basel, Switzerland) 27 (14) (2022)
Robert Kuhnert, Lydia Kuhnert, Menyhárt-Botond Sárosi, Sven George, Dijana Drača, Svetlana Paskaš, Bettina Hofmann, Dieter Steinhilber, Walther Honscha, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Borcalein: a Carborane-Based Analogue of Baicalein with 12-Lipoxygenase-Independent Toxicity. ChemMedChem (2021)
Antonio Buzharevski, Svetlana Paskaš, Menyhárt-Botond Sárosi, Markus Laube, Peter Lönnecke, Wilma Neumann, Sanja Mijatovic, Danijela Maksimović-Ivanić, Jens Pietzsch, Evamarie Hey-Hawkins
Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines. ChemMedChem 14 (3) (2019)